Thyroid cancers are quite rare, accounting for only 1.5% of all cancers in adults and 3% of all cancers in children, but the rate of new cases is increasing in the last decades. The highest incidence of thyroid carcinomas in the world is found among female Chinese residents of Hawaii. During the last few years, the frequency of papillary cancer has increased, but this increase in frequency is related to an improvement in diagnostic techniques and the information campaign about this carcinoma. Of all thyroid cancers, 74-80% of cases are papillary cancer. Follicular carcinoma incidences are higher in regions where incidence of endemic goiter is high.
Papillary thyroid cancer is characterized by its papillary architectural growth pattern but more importantly by the changes in the appearance of the nuclei of the tumor. Any cancerous nodule can become life-threatening by spreading via lymphatic spaces or blood vessels to lymph nodes or nearby bones and other organs. However, among all malignant neoplasms, there is a low death rate for papillary thyroid cancer.
Nodules can be detected when your primary care physician checks your neck and throat and feels the thyroid for lumps. Otherwise, early thyroid cancer does not have symptoms. If the cancer grows, symptoms may include a lump in the front of the neck, hoarseness or voice changes, swollen lymph nodes in the neck, trouble swallowing or breathing, or throat or neck pain.
Papillary Thyroid Cancer Risk Factors
Women are three times more likely than men to have papillary thyroid cancer. Most cases afflict individuals between the ages of 30 and 50. Associated risk factors include radiation exposure, a family history of thyroid cancer, and too much iodine in the diet. Less often, papillary thyroid cancer is associated with having a goiter, benign thyroid nodule, or multiple colon growths (familial polyposis). Also, papillary thyroid cancer has been linked to nuclear weapons testing in the western United States and to accidents in nuclear power plants and atomic weapons production facilities (for example, the Chernobyl nuclear facility accident).
Papillary Thyroid Cancer Diagnosis
If patient symptoms suggest the possibility of thyroid cancer, usually physician will order a blood test that the pathologist will check for abnormal levels of thyroid-stimulating hormone (TSH). Too much or too little TSH shows that the thyroid is not working well. Blood test results also can show a changed RET (Rearranged during Transfection) gene passed from parent to child.
Physician may order an ultrasound and thyroid scan for review by radiologists. Cells removed by fine-needle aspiration (FNA) or tissue removed by a biopsy are sent to the pathologist to examine. An ultrasound or thyroid scan creates images of thyroid nodules that the radiologist can view for signs of cancer. An FNA or a biopsy, however, are the only potential sure ways to diagnose cancer.
papillary thyroid cancer Stage
Pathologist and primary care doctor determine the cancer’s stage to plan the best treatment. This process involves determining the size of the cancerous nodule, whether or not the cancer has spread and, if so, to what parts of the body. Thyroid cancer spreads most often to the lymph nodes, and much less often to the lungs and to bones. Stage 1 cancers are small and confined to the thyroid, and stage 4 tumors have spread well beyond the thyroid. Stages 2 and 3 describe conditions in between these two extremes. Staging may involve tests such as ultrasound, CT or MRI scans, chest x-rays, or whole body scans. These tests enable the pathologist to determine where the cancer has spread and its stage.
Papillary Thyroid Cancer Treatment
papillary thyroid cancer Treatment will depend on the size of the nodule, your age, and whether or not the cancer has spread. The pathologist consults with your primary care physician or specialist. Together, using their combined experience and knowledge, they determine treatment options most appropriate for your condition. It’s important to learn as much as you can about your treatment options and make the decision that’s right for you.
Papillary thyroid cancer may be treated with surgery, external radiation therapy, thyroid hormone treatment, radioactive iodine therapy, or chemotherapy. Many patients receive a combination of these treatments. Surgery and external radiation therapy are local therapies that remove or destroy cancer in the thyroid. When the cancer has spread beyond the thyroid, these two therapies can control the disease in the thyroid. Common surgical procedures are the total thyroidectomy (removal of the entire thyroid gland), the lobectomy (removal of part of the thyroid), and lymphectomy, which removes lymph nodes where the cancer has spread. External radiation therapy is generally used after surgery; this therapy uses high-energy beams projected from outside the body to destroy any remaining cancer. Thyroid hormone treatment, radioactive iodine therapy, and chemotherapy are systemic therapies delivered through the bloodstream to destroy or stop the progression of cancer cells present throughout the body. These therapies also can reduce pain.
Any of these treatments may cause side effects and alter your normal activities. Ask your primary care physician or specialist to explain possible side effects thoroughly. If your treatment removes or destroys your entire thyroid, or a large portion of your thyroid, you will be required to take thyroid hormone pills for the rest of your life to replace the natural thyroid hormone. If the surgeon removes the parathyroid glands, located behind the thyroid, you will need to take calcium and vitamin D supplements for the rest of your life.
Follow-up care is very important because thyroid cancer comes back in up to 30 percent of all cases. Also, if you receive radioactive iodine therapy or external radiation therapy, you have an increased chance of developing other cancers later in your life. You should receive regular blood tests to check your levels of TSH and thyroglobulin (thyroid hormone stored in the thyroid). Your physicians also may recommend repeating some of the diagnostic and staging tests to see if the cancer has returned.
